Evidence-based Diagnosis: A Workshop on Evaluating and Using Medical Tests Small Group 3: Friday, June 10, 11:00 12:30. Problems Without Answers
|
|
- Mary Armstrong
- 5 years ago
- Views:
Transcription
1 Evidence-based Diagnosis: A Workshop on Evaluating and Using Medical Tests Small Group 3: Friday, June 10, 11:00 12:30 A B C D E Objectives: RCT Checklist RRR vs. ARR NNT = 1/ARR NNH = 1/ARI NNT Treatment Cost Problems Without Answers Problem Topic Difficulty 1 Oseltamivir for Post Exposure Prophylaxis Beginner X X 2 Marcolide Antibiotics for Pertussis TO BE WRITTEN 3 Warfarin for VTE TO BE WRITTEN 4 Early Goal-Directed Therapy for Sepsis Beginner X X 5 Aspirin and t-pa for Acute MI (Same as EBD Problem 9.5) Beginner X X 6 Clopidogrel (Plavix) for TIA Beginner X X X 7 t-pa for Acute Ischemic Stroke Beginner X X 8 Coiling vs. Clipping for Aneurysmal Bleeding Beginner X X RCT Checklist RRR vs. ARR NNT = 1/ARR NNH = 1/ARI NNT Treatment Cost Page 1 of 8 1
2 1. Oseltamivir for Post Exposure Prophylaxis Case: The patient is a 6-year-old girl with fever, myalgias, cough and sore throat for 1 day. A rapid antigen test for influenza is positive. (See SG-1, Problem 1.) Her mother is 12 weeks pregnant and does not have any flu symptoms at this time. Setting aside the question of whether to treat the patient herself with oseltamivir, we will focus on the question of whether to treat her mother with prophylactic oseltamivir. Welliver et al(1) did a randomized trial of prophylactic oseltamivir to prevent influenza in household contacts of patients with clinical influenza. The table below summarized their results in the subgroup where the index case was (like the 6-year-old in this question) positive for influenza. Household Contacts of Flu+ Index Cases Flu No Flu Risk Oseltamivir /209 = 1.4% Placebo /206 = 12.6% a) Calculate the NNT and explain how to interpret it. Prophylactic oseltamivir dosing is 75 mg daily for 5 days. This drug cost is about $50. b) In household contacts such as the mother in this problem, how much to you have to spend in oseltamivir to prevent one case of the flu. Now consider the question of whether it was worth doing a rapid antigen test on the 6-yearold girl for flu purely to guide prophylaxis in the mother. Things get complicated here, because Welliver et al used the PCR (gold standard) to determine whether the index case had the flu. The rapid flu test can be assumed to be 100% specific relative to the PCR but only 50% sensitive. Assumptions: Prophylactic oseltamivir is of no benefit if the index case is gold-standard (PCR) negative for the flu. It is worth $250 in oseltamivir costs to reduce the mother s risk of flu by the amount shown in the table above. Since the actual treatment cost is only $50, net gain of prophylactic treatment is $250 - $50 = $200. Page 2 of 8 2
3 You could also look at this as the cost B of failing to treat the mother if the index patient is gold-standard (PCR) positive. The rapid influenza test costs $10. Ignore the side effects of oseltamivir (which are minimal) and the issue of increasing oseltamivir resistance. c) At what range of flu probabilities does it make sense to test the index case in order to guide prophylactic treatment of the household contact? (You may use this link.) d) This is a good opportunity to play with the spreadsheet. What happens if the rapid test is free? 2. Marcolide Antibiotics for Pertussis 3. Warfarin for VTE 4. Early Goal-Directed Therapy for Sepsis Rivers et al (2) performed a noteworthy and somewhat controversial clinical trial of Early Goal Directed Therapy (EGDT) to reduce 28-day mortality in patients with severe sepsis and septic shock. The main results are shown in the following table. Dead within 28 days Mortalit y Yes No Total EGDT Standard a) How many patients with severe sepsis do you have to treat with EGDT instead of standard care to save one from dying within 28 days? Early Goal Directed Therapy was a bundle of interventions performed according to a protocol in a special ED unit by a trained team consisting of an attending emergency physician, 2 emergency medicine residents, and 3 nurses. Here is the paper s description of the protocol: The protocol was as follows. A 500-ml bolus of crystalloid was given every 30 minutes to achieve a central venous pressure of 8 to 12 mm Hg. If the mean arterial pressure was less than 65 mm Hg, vasopressors were given to maintain a mean arterial pressure of at least 65 mm Hg. If the mean arterial pressure was greater than 90 mm Hg, vasodilators were given until it was 90 mm Hg or below. If the central venous oxygen saturation was less than 70 percent, red cells Page 3 of 8 3
4 were transfused to achieve a hematocrit of at least 30 percent. After the central venous pressure, mean arterial pressure, and hematocrit were thus optimized, if the central venous oxygen saturation was less than 70 percent, dobutamine administration was started at a dose of 2.5 μg per kilogram of body weight per minute, a dose that was increased by 2.5 μg per kilogram per minute every 30 minutes until the central venous oxygen saturation was 70 percent or higher or until a maximal dose of 20 μg per kilogram per minute was given. Dobutamine was decreased in dose or discontinued if the mean arterial pressure was less than 65 mm Hg or if the heart rate was above 120 beats per minute. To decrease oxygen consumption, patients in whom hemodynamic optimization could not be achieved received mechanical ventilation and sedatives. Standard Therapy was also performed in the same unit by the same team. Both EGDT and standard therapy involved placing a central venous line, but once the line was placed the standard therapy patients were admitted to the ICU, while the EGDT patients were kept in the ED unit for 6+ hours. The physicians who ultimately assumed care in the ICU were blinded to initial treatment group. One of the main enrollment criteria for this study was a serum lactate >= 4.0 mmol/l. At many community hospitals, including Mills-Peninsula Hospital in Burlingame, this study has resulted in an imperative to place a central line in all patients with a significant infection and a lactate >= 4.0. b) Is this imperative to place a central line in all patients with severe sepsis consistent with the results to this study? Explain your answer. 5. Aspirin and t-pa for Acute MI (Same as EBD Problem 9.5) In the chapter, we learned from the ISIS-2 Study (3) that aspirin therapy (one month of 160 mg/day) in patients with acute myocardial infarction (AMI) reduced 30-day cardiovascular mortality from 11.8% in the placebo group to 9.4% in the aspirin group (P < ). a) What is the absolute risk reduction (ARR)? b) How many AMI patients need to be treated with aspirin for 30 days to prevent one death? c) A 120-pill bottle of 81 mg aspirin tablets costs about $5.00. Considering only the cost of the treatment drug, use this to calculate the cost effectiveness ratio ($/Cardiovascular death prevented) for aspirin therapy of AMI. (Be careful, you only need 60 aspirin pills to treat one patient for 30 days.) ISIS-2 and other studies also showed that, when added to aspirin, thrombolysis with streptokinase reduced mortality even further. The GUSTO Study (4) compared thrombolysis using tissue plasminogen activator (tpa) with thrombolysis using streptokinase (SK) in reducing the 30-day mortality of patients with acute myocardial infarction (AMI) receiving aspirin. This study showed a 14% relative risk reduction in the tpa-treated patients. Controversy exists because other large studies found no difference in 30-day mortality. Also, only the subgroup of US (not European) patients showed a benefit, and it was not a blinded study. However, for this problem assume that the 14% relative risk reduction is real. The 30-day mortality risk in the SK group was 7.3%. Page 4 of 8 4
5 d) What was the 30-day mortality risk in the tpa group? e) What was the absolute risk reduction associated with tpa (vs. SK)? f) How many patients need to be treated with tpa instead of SK to prevent one death? g) The cost of tpa is about $3400 per course of treatment, and the cost of SK is about $ (5) What is the approximate treatment drug cost per death prevented by using tpa instead of SK? 6. Clopidogrel (Plavix) for TIA The Fast Assessment of Stroke and TIA to prevent Early Recurrence (FASTER) Trial was a randomized controlled trial of clopidogrel (Plavix ) vs. placebo to prevent stroke at 90 days in patients within 24 hours of TIA.(6) All patients in the trial received aspirin. Here are the results: TOTAL Stroke No Stroke Clopidogrel Placebo A protocol referring to this study stated clopidogrel combined with aspirin reduced the 90-day risk of stroke by 36% compared to aspirin alone in a pilot trial of 392 patients treated acutely after minor stroke or TIA, and it was well tolerated. a) To what measure of treatment effect (e.g. RR, OR, RRR, ARR, etc.) does the 36% refer? 1 Current prices are SK $563 and tpa (alteplase) $3405, so the extra cost of tpa is now $2842. (See Peacock et al, 2007) Page 5 of 8 5
6 b) Based on this study result, how many TIA patients do we have to treat with colpidogrel plus aspirin instead of aspirin alone to prevent 1 from having a stroke in the subsequent 90 days? Currently clopidogrel is available only as Plavix manufactured by Bristol-Myers Squibb in conjunction with Sanofi-Aventis Pharmaceuticals. (It is expected to go off patent in 2011.) A quick look at drugstore.com (11/7/2010) shows that 1 pill costs about $5. A 90 day course of clopidogrel requires 97 pills (each 75 mg). This is because the first dose is 8 pills, then 1 pill per day afterwards. At the price of $5 per pill, how much does it cost in Plavix alone to prevent 1 stroke at 90 days in a TIA patient (whom you can treat within 24 hours of symptoms onset). 7. t-pa for Acute Ischemic Stroke A New York Times article (5/28/2007) summarized the results of the NINDS randomized blinded trial of t-pa (tissue plasminogen activator) within 3 hours of symptom onset in acute ischemic stroke.(7) In 1995, after 40 years of trying to find something to break up blood clots in the brain, the cause of most strokes, researchers announced that tpa worked. A large federal study showed that, without it, about one patient in five escaped serious injury. With it, one in three escaped. The drug had a serious side effect it could cause potentially life-threatening bleeding in the brain in about 6 percent of patients. This is an accurate summary of the study s results, although we emphasize that the study was limited to patients within 3 hours of symptom onset. a) What was the risk of serious injury in the placebo group? b) What was the risk of serious injury in the t-pa group? c) What is the absolute risk reduction (ARR) and number needed to treat (NNT) with tpa to prevent one ischemic stroke patient from suffering serious injury? d) What is tpa s absolute risk increase (ARI) for serious intracranial bleed ( bleeding in the brain )? What is the number needed to harm? Page 6 of 8 6
7 e) How many serious injuries are prevented for each serious intracranial bleed caused? (Warning: the serious intracranial bleeds were also counted as serious injuries the primary study outcome.) 8. Coiling versus Clipping for Bleeding Cerebral Aneurysms Case: A previously health 62 year old man presents to the ED with 24-hours of headache. (See SG-1, Problem 8.) A CT of the brain shows subarachnoid hemorrhage and magnetic resonance angiography shows a leaking cerebral artery aneurysm. (For those who want more detail, it is an 8 x 7 x 7 mm leaking anterior communicating artery aneurysm with localized adjacent subarachnoid hemorrhage in the interhemispheric fissure and medial margin of the right sylvian fissure. ) Clinical Information: The question arises as to whether to treat this problem with clipping or coiling. Clipping is an operating room procedure that involves a craniotomy (opening the skull) and placing a metal clip at the base of the aneurysm. Coiling is a transvascular procedure done in the interventional radiology suite and involves passing an arterial catheter through the neck and into the brain, then occluding the aneurysm by feeding a thrombogenic wire into it. Clipping has higher operative risk but a lower chance of re-bleeding. The International Subarachnoid Aneurysm Treatment (ISAT) Trial(8) was a randomized trial of the effect of coiling vs. clipping on the outcome of death or dependency in patients with bleeding cerebral aneurysms who could be treated with either modality. Here are the results. Dead or Dependent at 12 months: Coil: 250/1063 = 24% (10 lost to f/u) Clip: 326/1055 = 31% (15 lost to f/u) a) What is the NNT? Explain it in a sentence that might be comprehensible to someone unfamiliar with NNT. b) It was impossible to blind the patients or their treating physicians to treatment group (coiling vs. clipping). The assessment of outcome (death or disability) was done by examiners/interviewers blinded to treatment group. How would these facts affect the trial results? Page 7 of 8 7
8 REFERENCES 1. Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. Jama Feb 14;285(6): Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med Nov 8;345(19): ISIS-2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet Aug 13;2(8607): GUSTO. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med Sep 2;329(10): Peacock WF, Hollander JE, Smalling RW, Bresler MJ. Reperfusion strategies in the emergency treatment of ST-segment elevation myocardial infarction. Am J Emerg Med Mar;25(3): Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol Nov;6(11): NINDS. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med Dec 14;333(24): Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet Sep 3-9;366(9488): Page 8 of 8 8
Neurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)
Neurosurgical decision making in structural lesions causing stroke Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery) Subarachnoid Hemorrhage Every year, an estimated 30,000 people in the United States experience
More information7 TI - Epidemiology of intracerebral hemorrhage.
1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg. 1998 Aug;1():-8. Review. IDS - PMID: 1000 UI: 991958 TI - Cerebral
More informationNIH Public Access Author Manuscript J Am Coll Radiol. Author manuscript; available in PMC 2013 June 24.
NIH Public Access Author Manuscript Published in final edited form as: J Am Coll Radiol. 2010 January ; 7(1): 73 76. doi:10.1016/j.jacr.2009.06.015. Cerebral Aneurysms Janet C. Miller, DPhil, Joshua A.
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationEpidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital
ISPUB.COM The Internet Journal of Neurosurgery Volume 9 Number 2 Epidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital A Granger, R Laherty Citation A Granger, R Laherty.
More informationEarly Goal-Directed Therapy
Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The
More informationWhat You Should Know About Cerebral Aneurysms
American Society of Neuroradiology American Society of Interventional & Therapeutic Neuroradiology What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Intervention Committee
More information325 mg aspirin and plavix
325 mg aspirin and plavix 12-3-2006 Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for. Compare Aspirin
More informationDr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre
Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic
More informationProtocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
More informationWHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE
WHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE Subarachnoid Hemorrhage is a serious, life-threatening type of hemorrhagic stroke caused by bleeding into the space surrounding the brain,
More informationJournal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study
Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec
More informationEvidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
More informationAspirin to Prevent Heart Attack and Stroke: What s the Right Dose?
The American Journal of Medicine (2006) 119, 198-202 REVIEW Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose? James E. Dalen, MD, MPH Professor Emeritus, University of Arizona, Tucson
More informationAndrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth. May 23, 2018
Andrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth May 23, 2018 Disclosure No personal financial relationships with any company. Presentation Outline Definitions, signs
More informationFrom the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council
American Society of Neuroradiology What Is a Stroke? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair
More informationUnclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018
Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy
More informationAcute myocardial infarction. Cardiovascular disorders. main/0202_new 02/03/06. Search date August 2004 Nicholas Danchin and Eric Durand
main/0202_new 02/03/06 Acute myocardial infarction Search date August 2004 Nicholas Danchin and Eric Durand QUESTIONS Which treatments improve outcomes in acute myocardial infarction?...4 Which treatments
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationBC Sepsis Network Emergency Department Sepsis Guidelines
The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationAcute stroke update 2016 innovations in managing ischemic and hemorrhagic disease
Acute stroke update 2016 innovations in managing ischemic and hemorrhagic disease Christopher Koebbe, MD Endovascular Neurosurgeon Florida Spine Institute Director of Neurosciences Northside Hospital Overview
More informationNeuroform Microdelivery Stent System
Neuroform Microdelivery Stent System Patient Information Booklet TABLE OF CONTENTS What is the Purpose of This Booklet?...2 What is a Wide Neck, Intracranial Aneurysm?...2 What is the Treatment for Wide
More informationDr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital
Stroke Management Dr Ben Turner Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Introduction Stroke is the major cause of disability in the developed
More informationConflicts of Interest: None. Aspirin, primary prevention and USPSTF. Primary prevention of ASCVD is important
Aspirin, primary prevention and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; February 2017 Conflicts of Interest: None Primary prevention of ASCVD is important Myocardial Infarction Incidence
More informationRecombinant Factor VIIa for Intracerebral Hemorrhage
Recombinant Factor VIIa for Intracerebral Hemorrhage January 24, 2006 Justin Lee Pharmacy Resident University Health Network Outline 1. Introduction to patient case 2. Overview of intracerebral hemorrhage
More informationAntithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding
Get With The Guidelines -Stroke is the American Heart Association s collaborative performance improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized with
More informationDept. of Neurosurgery, Division of Endovascular Neurosurgery, Medilaser Clinic, Tunja, Colombia 2
DOI: 10.17/sjmcr.01..1. Scholars Journal of Medical Case Reports Sch J Med Case Rep 01; (1):91-9 Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and
More informationCurrent Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach
Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationDawn Matherne Meyer PhD,RN,FNP-C. Assistant Professor University of California San Diego
Dawn Matherne Meyer PhD,RN,FNP-C Assistant Professor University of California San Diego Evidence Based Care of the Stroke Patient: A Focus on Acute Treatment, BP Management, & Antiplatelets TIME IS BRAIN
More informationENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist
ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning
More informationGuideline scope Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Stroke and transient ischaemic attack in over s: diagnosis and initial management (update) 0 0 This will update the NICE on stroke and
More informationThrombolysis, adjunctive pharmacology and interventions
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation ESC Annual Congress Munich, 2012 Thrombolysis, adjunctive pharmacology and interventions
More informationAMI Talking Points. Provide appropriate treatment to Acute MI patients with these core measures:
AMI Provide appropriate treatment to Acute MI patients with these core measures: Aspirin received within 24 hours of arrival or contraindication documented Primary PCI Received Within 90 Minutes of Hospital
More informationLong term follow-up after endovascular treatment for intracranial aneurysms. Bart Emmer, MD, PhD
Long term follow-up after endovascular treatment for intracranial aneurysms Bart Emmer, MD, PhD Coiling 2 International Subarachnoid Aneurysm Trial Molyneux et al. Lancet Oct 26 2002 Clipping vs Coiling
More informationSHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?
SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria Disclosures DISCLOSURE
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationClinical trial registration no.: NCT (clinicaltrials.gov) https://thejns.org/doi/abs/ / jns161301
CLINICAL ARTICLE J Neurosurg 128:120 125, 2018 Analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial Robert F. Spetzler, MD, 1 Joseph M. Zabramski, MD, 1 Cameron G. McDougall, MD, 1 Felipe
More informationInterventional Neuroradiology. & Stroke INR PROCEDURES INR PROCEDURES. Dr Steve Chryssidis. 25-Sep-17. Interventional Neuroradiology
Interventional Neuroradiology Interventional Neuroradiology & Stroke Dr Steve Chryssidis Interventional Neuroradiology (INR) is a subspecialty within Radiology INR -- broadly defined as treatment by endovascular
More informationHow to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval
How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval Peter Howard MD FRCPC Disclosures No conflicts to disclose How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular
More information03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE
CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no
More informationStroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013
Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment
More informationCase 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE Rhonda Whiteman Racing Against the Clock Workshop June 1, 2017 Objectives To discuss the hyperacute ischemic stroke management
More information4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures
Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare
More information- May Help Increase Appropriate Early Use in Acute Coronary Syndrome Patients -
MEDIA INVESTORS Ken Dominski John Elicker Bristol-Myers Squibb Bristol-Myers Squibb 609-252-5251 212-546-3775 ken.dominski@bms.com john.elicker@bms.com Amy Ba Felix Lauscher sanofi-aventis sanofi-aventis
More informationEmergency Treatment of Ischemic Stroke
Emergency Treatment of Ischemic Stroke JEFFREY BOYLE, M.D., PHD CLINICAL DIRECTOR OF STROKE AT AVERA MCKENNAN AVERA MEDICAL GROUP NEUROLOGY SIOUX FALLS, SD Conflicts of Interest None I will discuss therapies
More informationDECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.
DECLARATION OF CONFLICT OF INTEREST Lecture fees: AstraZeneca, Ely Lilly, Merck. Risk of stopping dual therapy. S D Kristensen, FESC Aarhus Denmark Acute coronary syndrome: coronary thrombus Platelets
More informationAntithrombotics 201: Aspirin and USPSTF. Presented by: Craig Williams, PharmD., BCPS., FNLA; November, Conflicts of Interest: None
Antithrombotics 201: Aspirin and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; November, 2016 Conflicts of Interest: None 1 What percent of patients who die within 30 days of an MI die before
More informationWhen the learner has completed this module, she/he will be able to:
Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationEFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationIntroducing a New Treatment Method for Brain Aneurysms
Pipeline Embolization Device Introducing a New Treatment Method for Brain Aneurysms UNDERSTANDING ANEURYSMS What is a brain aneurysm? An aneurysm is an outpouching in an artery caused by weakness in the
More informationCritical Review Form Therapy Objectives: Methods:
Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To
More informationAcute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center
Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting
More informationGuideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management
0 0 NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management The Department of Health and Social Care in England
More information(aneurysmal subarachnoid hemorrhage, 17%~60% :SAH. ,asah , 22%~49% : Willis. :1927 Moniz ;(3) 2. ischemic neurological deficit,dind) SAH) SAH ;(6)
,, 2. : ;,, :(1), (delayed ;(2) ischemic neurological deficit,dind) ;(3) 2. :SAH ;(4) 5-10 10 HT -1-1 ;(5), 10 SAH ;(6) - - 27%~50%, ( cerebral vasospasm ) Glasgow (Glasgow Coma Scale,GCS), [1],, (aneurysmal
More information5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016
Outpatient Stroke Management Sheila Smith MD May 5, 2016 1 Management of Outpatient Stroke Objectives Review blood pressure management post stroke Review antithrombotic therapy Review statin therapy Discuss
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationThrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!
Thrombolytic therapy should be the first line treatment in acute ishchemic stroke We are against it!! 85% of strokes are ischaemic, and related to blockage of an artery by a blood clot, so potential treatments
More informationAntithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)
Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase
More informationReview Statistics review 11: Assessing risk Viv Bewick 1, Liz Cheek 1 and Jonathan Ball 2
Available online http://ccforum.com/content/8/4/87 Review Statistics review 11: Assessing risk Viv Bewick 1, Liz Cheek 1 and Jonathan Ball 1 Senior Lecturer, School of Computing, Mathematical and Information
More informationFluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS
Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available
More informationPharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development
STROKE Anne Kinnear Lead Pharmacist NHS Lothian Aim To update pharmacists on Stroke: the disease and its management and explore ways to implement pharmaceutical care for this patient group as part of normal
More informationSubject Expert. Michelle Whaley MSN, CNS, CCNS, ANVP-BC Swedish Medical Center Englewood, CO
Stroke 101 Subject Expert Michelle Whaley MSN, CNS, CCNS, ANVP-BC Swedish Medical Center Englewood, CO 2 Objectives Types of strokes Stroke warning signs Stroke risk factors Medical test performed following
More informationStroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian
Stroke in the ED Dr. William Whiteley Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian 2016 RCP Guideline for Stroke RCP guidelines for acute ischaemic stroke
More informationStudying Aneurysm Devices in the Intracranial Neurovasculature
Studying Aneurysm Devices in the Intracranial Neurovasculature The benefits and risks of treating unruptured aneurysms depend on the anatomical location. One approach to studying devices to treat unruptured
More informationPipeline Embolization Device
Pipeline Embolization Device The power to redefine aneurysm treatment. REDEFINE The Pipeline device redefines treatment for large or giant wide-necked aneurysms by reconstructing the parent artery and
More informationNeurointensive Care of Aneurysmal Subarachnoid Hemorrhage. Alejandro A. Rabinstein Department of Neurology Mayo Clinic, Rochester, USA
Neurointensive Care of Aneurysmal Subarachnoid Hemorrhage Alejandro A. Rabinstein Department of Neurology Mayo Clinic, Rochester, USA The traditional view: asah is a bad disease Pre-hospital mortality
More informationSTROKE INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:
STROKE INTRODUCTION Stroke is the medical term for a specific type of neurological event that causes damage to the brain. There are two types of stroke, but both types of stroke cause the same type of
More informationRed Cell Transfusion triggers: A moving target When, who, and how much?
Red Cell Transfusion triggers: A moving target When, who, and how much? Tim Walsh Professor of Critical Care, Edinburgh University A transfusion threshold of 70 g/l or below, with a target Hb range of
More informationUnderstanding aneurysms and flow diversion treatment
Surpass Streamline Flow Diverter See package insert for complete indications, contraindications, warnings and instructions for use. INTENDED USE / INDICATIONS FOR USE The Surpass Streamline Flow Diverter
More informationWEB device for treating brain (intracranial) aneurysms
WEB device for treating brain (intracranial) aneurysms This leaflet explains more about the WEB device, including the benefits, risks and any alternatives and what you can expect when you come to hospital.
More informationDefinition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure
Seizures after stroke Can we predict? พ.ญ.ส ธ ดา เย นจ นทร PMK Epilepsy Annual Meeting 2016 Definition Poststroke seizure : single or multiple convulsive episode(s) after stroke and thought to be related
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationClopidogrel has been evaluated in clinical trials that included cardiovascular patients
REVIEW ARTICLE Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations Lessons From the CAPRIE and CURE Studies Jack Hirsh, CM, MD, FRCPC, FRACP, FRSC, DSc; Deepak L. Bhatt, MD,
More informationACUTE ISCHEMIC STROKE
ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE HHS Stroke Annual Review March 7 and March 8, 2018 Objectives To review the stroke endovascular mechanical thrombectomy evidence
More informationMulti-modality management of intracranial aneurysms
Multi-modality management of intracranial aneurysms Christopher Koebbe, Maj, USAF, MC Staff Neurosurgeon San Antonio Military Medical Consortium Clinical Assistant Professor Department of Neurological
More informationStroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University
More informationFrom interventional cardiology to cardio-neurology. A new subspeciality
From interventional cardiology to cardio-neurology. A new subspeciality in the future? Prof. Andrejs Erglis, MD, PhD Pauls Stradins Clinical University Hospital University of Latvia Riga, LATVIA Disclosure
More informationINDUCED HYPOTHERMIA A Hot Topic. R. Darrell Nelson, MD, FACEP Emergency Medicine Wake Forest University Health Sciences
INDUCED HYPOTHERMIA A Hot Topic R. Darrell Nelson, MD, FACEP Emergency Medicine Wake Forest University Health Sciences Conflicts of Interest Sadly, we have no financial or industrial conflicts of interest
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationMEDICAL POLICY EFFECTIVE DATE: 12/18/08 REVISED DATE: 12/17/09, 03/17/11, 05/19/11, 05/24/12, 05/23/13, 05/22/14
MEDICAL POLICY SUBJECT: CT (COMPUTED TOMOGRAPHY) PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationCerebrovascular Disease lll. Acute Ischemic Stroke. Use of Intravenous Alteplace in Acute Ischemic Stroke Louis R Caplan MD
Cerebrovascular Disease lll. Acute Ischemic Stroke Use of Intravenous Alteplace in Acute Ischemic Stroke Louis R Caplan MD Thrombolysis was abandoned as a stroke treatment in the 1960s due to an unacceptable
More informationTime-resolved Magnetic Resonance Angiography for assessment of recanalization after coil embolization of visceral artery aneurysms
Signature: Pol J Radiol, 2013; 78(1): 64-68 DOI: 10.12659/PJR.883769 CASE REPORT Received: 2012.09.29 Accepted: 2013.01.15 Time-resolved Magnetic Resonance Angiography for assessment of recanalization
More informationEarly Goal Directed Therapy in 2015: What Did the Big Trials Teach us?
Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us? Mitchell M. Levy MD, FCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care Warren Alpert Medical School
More informationWHAT IS A STROKE? What causes a stroke? What disabilities can result from a stroke?
Know Stroke Stroke is the third leading cause of death in the United States and a leading cause of serious, long-term disability in adults. About 600,000 new strokes are reported in the U.S. each year.
More informationStroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012
Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model
More informationSTROKE UPDATE ANTHEA PARRY MAY 2010
STROKE UPDATE ANTHEA PARRY MAY 2010 Delivery of stroke care Clinical presentations Management Health Care for London plan 8 HASU (hyperacute) units 20 stroke units TIA services Hyperacute stroke units
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationNothing to disclose 9/25/2017
Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain
More informationEmergency Department Management of Acute Ischemic Stroke
Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,
More information2017 Stroke Statistics
2017 Stroke Statistics 2017 LUMC Stroke Volumes by Type of Stroke Ischemic Stroke Treatment by Type 2017 17% 8% 75% Ischemic Intracerebral Hemorrhage Aneurysmal Subarachnoid Hemorrhage 31 42 25 r-tpa Administered
More information9/25/2017. Nothing to disclose
Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain
More informationSepsis Management Update 2014
Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma
More information